Back to Journals » Drug Design, Development and Therapy

Drug Design, Development and Therapy

ISSN: 1177-8881


Editor-in-Chief: Prof. Dr. Frank Boeckler

An international, peer-reviewed, open access journal that spans the spectrum of drug design and development through to clinical applications. The journal is characterized by the rapid reporting of application notes, reviews, original research and clinical studies in all therapeutic areas. Clinical outcomes, patient safety, and programs for the development and effective, safe, and sustained use of medicines will be a feature of the journal. 

This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE).

Latest articles:

- 5 records -

Lawsone Unleashed: A Comprehensive Review on Chemistry, Biosynthesis, and Therapeutic Potentials

Nair AS, Sekar M, Gan SH, Kumarasamy V, Subramaniyan V, Wu YS, Mat Rani NNI, Ravi S, Wong LS

Drug Design, Development and Therapy 2024, 18:3295-3313

Published Date: 26 July 2024

Research Progress of Triptolide Against Fibrosis

Jiang M, Xie Y, Wang P, Du M, Wang Y, Yan S

Drug Design, Development and Therapy 2024, 18:3255-3266

Published Date: 25 July 2024

Flavonoids and Gastric Cancer Therapy: From Signaling Pathway to Therapeutic Significance

Cai J, Tan X, Hu Q, Pan H, Zhao M, Guo C, Zeng J, Ma X, Zhao Y

Drug Design, Development and Therapy 2024, 18:3233-3253

Published Date: 25 July 2024

Chuanxiong Renshen Decoction Inhibits Alzheimer’s Disease Neuroinflammation by Regulating PPARγ/NF-κB Pathway

Hou J, Wang X, Zhang J, Shen Z, Li X, Yang Y

Drug Design, Development and Therapy 2024, 18:3209-3232

Published Date: 24 July 2024


Read more articles